Chen N, Alam AB, Lutsey PL, MacLehose RF, Claxton JS, Chen LY et al (2020) Polypharmacy, adverse outcomes, and treatment effectiveness in patients ≥75 with atrial fibrillation. J Am Heart Assoc. https://doi.org/10.1161/JAHA.119.015089

Article  PubMed  PubMed Central  Google Scholar 

Kocis PT, Liu G, Makenbaeva D, Trocio J, Velott D, Trainer JB et al (2016) Use of chronic medications among patients with non-valvular atrial fibrillation. Drugs Real World Outcomes 3:165–173. https://doi.org/10.1007/s40801-016-0072-7

Article  PubMed  PubMed Central  Google Scholar 

Shaikh F, Pasch LB, Newton PJ, Bajorek BV, Ferguson C (2018) Addressing multimorbidity and polypharmacy in individuals with atrial fibrillation. Curr Cardiol Rep 20:32. https://doi.org/10.1007/s11886-018-0975-x

Article  PubMed  Google Scholar 

Gallagher C, Nyfort-Hansen K, Rowett D, Wong CX, Middeldorp ME, Mahajan R et al (2020) Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis. Open Heart 7:e001257. https://doi.org/10.1136/openhrt-2020-001257

Article  PubMed  PubMed Central  Google Scholar 

Azoulay L, Dell’Aniello S, Simon T, Renoux C, Suissa S (2013) The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost 109:431–439. https://doi.org/10.1160/TH12-08-0542

Article  CAS  PubMed  Google Scholar 

Chang K-H, Chen C-M, Wang C-L, Tu H-T, Huang Y-T, Wu H-C et al (2022) Major bleeding risk in patients with non-valvular atrial fibrillation concurrently taking direct oral anticoagulants and antidepressants. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2022.791285

Article  PubMed  PubMed Central  Google Scholar 

Grymonprez M, Petrovic M, De Backer TL, Steurbaut S, Lahousse L (2024) The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Thromb Haemost 124:135–148. https://doi.org/10.1055/s-0043-1769735

Article  PubMed  Google Scholar 

Romiti GF, Corica B, Mei DA, Bisson A, Boriani G, Olshansky B et al (2024) Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry. BMC Med 22:151. https://doi.org/10.1186/s12916-024-03373-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Romiti GF, Proietti M, Vitolo M, Bonini N, Fawzy AM, Ding WY et al (2022) Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry. BMC Med. https://doi.org/10.1186/s12916-022-02526-7

Article  PubMed  PubMed Central  Google Scholar 

Proietti M, Raparelli V, Olshansky B, Lip GYH (2016) Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial. Clin Res Cardiol 105:412–420. https://doi.org/10.1007/s00392-015-0936-y

Article  CAS  PubMed  Google Scholar 

Buja A, Rebba V, Montecchio L, Renzo G, Baldo V, Cocchio S et al (2024) The cost of atrial fibrillation: a systematic review. Value Health 27:527–541. https://doi.org/10.1016/j.jval.2023.12.015

Article  PubMed  Google Scholar 

Tazzeo C, Rizzuto D, Calderón-Larrañaga A, Roso-Llorach A, Marengoni A, Welmer A-K et al (2021) Multimorbidity patterns and risk of frailty in older community-dwelling adults: a population-based cohort study. Age Ageing 50:2183–2191. https://doi.org/10.1093/ageing/afab138

Article  PubMed  PubMed Central  Google Scholar 

Romiti GF, Proietti M, Bonini N, Ding WY, Boriani G, Huisman MV et al (2022) Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry phase II and III. Thromb Haemost 122:2030–2041. https://doi.org/10.1055/s-0042-1756355

Article  PubMed  Google Scholar 

Krittayaphong R, Treewaree S, Wongtheptien W, Kaewkumdee P, Lip GYH (2024) Clinical phenotype classification to predict risk and optimize the management of patients with atrial fibrillation using the Atrial Fibrillation Better Care (ABC) pathway: a report from the COOL-AF registry. QJM 117:16–23. https://doi.org/10.1093/qjmed/hcad219

Article  CAS  PubMed  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808. https://doi.org/10.1136/bmj.39335.541782.AD

Article  Google Scholar 

Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG et al (2021) 2021 European Heart Rhythm association practical guide on the use of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation. EP Europace 23:1612–1676. https://doi.org/10.1093/europace/euab065

Article  Google Scholar 

CHA₂DS₂-VASc score for atrial fibrillation. https://www.mdcalc.com/calc/801/cha2ds2-vasc-score-atrial-fibrillation-stroke-risk. (Date Accessed: 22082024) n.d.

Mei DA, Imberti JF, Bonini N, Romiti GF, Corica B, Proietti M et al (2024) Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: a report from a prospective European observational registry. Eur J Intern Med. https://doi.org/10.1016/j.ejim.2024.06.022

Article  PubMed  Google Scholar 

World Health Organization (WHO). Accidental falls definition. https://www.whoint/news-room/fact-sheets/detail/falls (Date Accessed: 09092024) n.d.

Weller BE, Bowen NK, Faubert SJ (2020) Latent class analysis: a guide to best practice. J Black Psychol 46:287–311. https://doi.org/10.1177/0095798420930932

Article  Google Scholar 

Violán C, Fernández-Bertolín S, Guisado-Clavero M, Foguet-Boreu Q, Valderas JM, Vidal Manzano J et al (2020) Five-year trajectories of multimorbidity patterns in an elderly Mediterranean population using Hidden Markov Models. Sci Rep 10:16879. https://doi.org/10.1038/s41598-020-73231-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pastori D, Antonucci E, Milanese A, Menichelli D, Palareti G, Farcomeni A et al (2022) Clinical phenotypes of atrial fibrillation and mortality risk—a cluster analysis from the nationwide Italian START registry. J Pers Med 12:785. https://doi.org/10.3390/jpm12050785

Article  PubMed  PubMed Central  Google Scholar 

Larsen FB, Pedersen MH, Friis K, Glümer C, Lasgaard M (2017) A latent class analysis of multimorbidity and the relationship to socio-demographic factors and health-related quality of life. A national population-based study of 162,283 Danish Adults. PLoS ONE 12:e0169426. https://doi.org/10.1371/journal.pone.0169426

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park B, Lee HA, Park H (2019) Use of latent class analysis to identify multimorbidity patterns and associated factors in Korean adults aged 50 years and older. PLoS One 14:e0216259. https://doi.org/10.1371/journal.pone.0216259

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong Y, Qin G, Xi H, Cai D, Wang Y, Wang T et al (2023) Prevalence, patterns of multimorbidity and associations with health care utilization among middle-aged and older people in China. BMC Public Health 23:537. https://doi.org/10.1186/s12889-023-15412-5

Article  PubMed  PubMed Central  Google Scholar 

De Almeida Mello J, Proost B, Damiano C, Vetrano DL, Declercq A, Nova A (2023) Identification of multimorbidity patterns in older adults receiving long-term care in Canada, Italy, Finland and New Zealand: results from the ICARE4OLD project. Int J Integr Care 23:586. https://doi.org/10.5334/ijic.ICIC23563

Article  Google Scholar 

Dai L, Larranaga AC, Damiano C, Cordsen P, Luo H, Wastesson J et al (2023) Comorbidity patterns and health-related outcomes in older adults with atrial fibrillation: nationwide population-based findings from swedish national patient register. Eur Heart J. https://doi.org/10.1093/eurheartj/ehad655.2659

Article  PubMed  PubMed Central  Google Scholar 

Roso-Llorach A, Vetrano DL, Trevisan C, Fernández S, Guisado-Clavero M, Carrasco-Ribelles LA et al (2022) 12-year evolution of multimorbidity patterns among older adults based on Hidden Markov Models. Aging 14:9805–9817. https://doi.org/10.18632/aging.204395

Article  PubMed  PubMed Central  Google Scholar 

Damiano C, Onder G, Zazzara MB, Carfì A, Zucchelli A, Marengoni A et al (2022) Frailty, multimorbidity patterns and mortality in institutionalized older adults in Italy. Aging Clin Exp Res 34:3123–3130. https://doi.org/10.1007/s40520-022-02269-8

Article  PubMed  PubMed Central